Eris Biotech
Our drugs engage the immune system to fight tumors
Evita Weagel, Rachel Garlick · 2 co-founders
Profile coverage4 of 8 · missing Funding, Signals, Customers, Stack / tools · last run 8/10/2026
About
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.